Cargando…
Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis
BACKGROUND: The pathogenesis of progressive renal insufficiency in autosomal dominant polycystic kidney disease (ADPKD) is unclear. Evidence from experimental models of ADPKD suggests that elevated endothelin-1 (ET-1) drives cyst growth, renal fibrosis and loss of renal function, but whether ET-1 is...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770683/ https://www.ncbi.nlm.nih.gov/pubmed/26923419 http://dx.doi.org/10.1186/s12882-016-0232-8 |
_version_ | 1782418311221346304 |
---|---|
author | Raina, Rupesh Lou, Linda Berger, Bruce Vogt, Beth Do, Angelique Sao-Mai Cunningham, Robert Vasavada, Pauravi Herrmann, Karin Dell, Katherine Simonson, Michael |
author_facet | Raina, Rupesh Lou, Linda Berger, Bruce Vogt, Beth Do, Angelique Sao-Mai Cunningham, Robert Vasavada, Pauravi Herrmann, Karin Dell, Katherine Simonson, Michael |
author_sort | Raina, Rupesh |
collection | PubMed |
description | BACKGROUND: The pathogenesis of progressive renal insufficiency in autosomal dominant polycystic kidney disease (ADPKD) is unclear. Evidence from experimental models of ADPKD suggests that elevated endothelin-1 (ET-1) drives cyst growth, renal fibrosis and loss of renal function, but whether ET-1 is elevated in humans with ADPKD is uncertain. METHODS: In a cross-sectional study of ADPKD we measured urinary ET-1, a surrogate for ET-1 in kidney cortex, in spot collections corrected for creatinine. The volume of each kidney was measured using MRI-based stereology. The relationship of urine ET-1 with MDRD eGFR and kidney volume was modeled by multiple linear regression with adjustment for clinical covariates. RESULTS: Patients with ADPKD were ages 18 to 53 with eGFRs (median, interquartile range) of 63.2 (43.5–80.2) ml/min/1.73 m(2) and albumin/creatinine ratios (ACR) of 115.0 (7.5–58.5) μg/mg. Urine ET-1 was inversely associated with eGFR (r = −0.480, P < 0.05) and positively (r = 0.407, P = 0.066) with ACR independent of age and female sex (P < 0.01). ET-1 appeared to be positively associated with total kidney volume (r = 0.426, P = 0.100), with a test for trend across urine ET-1 quartiles yielding z = 1.83, P = 0.068. ET-1 strongly correlated with NAGase (r = 0. 687, P = 0.001), a marker of tubular damage and a surrogate marker of renal disease progression in ADPKD. Of note, ET-1 levels in urine were not correlated with hypertension. CONCLUSIONS: In a translational study of patients with ADPKD, urinary ET-1 was inversely associated with eGFR and positively correlated with total kidney volume. Taken together with results from experimental models, these findings suggest that the role of ET-1 in ADPKD warrants further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-016-0232-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4770683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47706832016-03-01 Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis Raina, Rupesh Lou, Linda Berger, Bruce Vogt, Beth Do, Angelique Sao-Mai Cunningham, Robert Vasavada, Pauravi Herrmann, Karin Dell, Katherine Simonson, Michael BMC Nephrol Research Article BACKGROUND: The pathogenesis of progressive renal insufficiency in autosomal dominant polycystic kidney disease (ADPKD) is unclear. Evidence from experimental models of ADPKD suggests that elevated endothelin-1 (ET-1) drives cyst growth, renal fibrosis and loss of renal function, but whether ET-1 is elevated in humans with ADPKD is uncertain. METHODS: In a cross-sectional study of ADPKD we measured urinary ET-1, a surrogate for ET-1 in kidney cortex, in spot collections corrected for creatinine. The volume of each kidney was measured using MRI-based stereology. The relationship of urine ET-1 with MDRD eGFR and kidney volume was modeled by multiple linear regression with adjustment for clinical covariates. RESULTS: Patients with ADPKD were ages 18 to 53 with eGFRs (median, interquartile range) of 63.2 (43.5–80.2) ml/min/1.73 m(2) and albumin/creatinine ratios (ACR) of 115.0 (7.5–58.5) μg/mg. Urine ET-1 was inversely associated with eGFR (r = −0.480, P < 0.05) and positively (r = 0.407, P = 0.066) with ACR independent of age and female sex (P < 0.01). ET-1 appeared to be positively associated with total kidney volume (r = 0.426, P = 0.100), with a test for trend across urine ET-1 quartiles yielding z = 1.83, P = 0.068. ET-1 strongly correlated with NAGase (r = 0. 687, P = 0.001), a marker of tubular damage and a surrogate marker of renal disease progression in ADPKD. Of note, ET-1 levels in urine were not correlated with hypertension. CONCLUSIONS: In a translational study of patients with ADPKD, urinary ET-1 was inversely associated with eGFR and positively correlated with total kidney volume. Taken together with results from experimental models, these findings suggest that the role of ET-1 in ADPKD warrants further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-016-0232-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-29 /pmc/articles/PMC4770683/ /pubmed/26923419 http://dx.doi.org/10.1186/s12882-016-0232-8 Text en © Raina et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Raina, Rupesh Lou, Linda Berger, Bruce Vogt, Beth Do, Angelique Sao-Mai Cunningham, Robert Vasavada, Pauravi Herrmann, Karin Dell, Katherine Simonson, Michael Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis |
title | Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis |
title_full | Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis |
title_fullStr | Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis |
title_full_unstemmed | Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis |
title_short | Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis |
title_sort | relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770683/ https://www.ncbi.nlm.nih.gov/pubmed/26923419 http://dx.doi.org/10.1186/s12882-016-0232-8 |
work_keys_str_mv | AT rainarupesh relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT loulinda relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT bergerbruce relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT vogtbeth relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT doangeliquesaomai relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT cunninghamrobert relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT vasavadapauravi relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT herrmannkarin relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT dellkatherine relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis AT simonsonmichael relationshipofurinaryendothelin1withestimatedglomerularfiltrationrateinautosomaldominantpolycystickidneydiseaseapilotcrosssectionalanalysis |